Pathology of familial breast cancer: Differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases

Lancet

Volumn 349, Issue 9064, 1997, Pages 1505-1510

  Stratton, Michael R ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER GRADING; CANCER SCREENING; CANCER SUSCEPTIBILITY; CARCINOMA IN SITU; COMPARATIVE STUDY; CONTROLLED STUDY; FAMILIAL CANCER; FEMALE; GENE MUTATION; HETEROZYGOTE; HISTOLOGY; HUMAN; HUMAN TISSUE; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; MEDULLARY CARCINOMA; MITOSIS; MORPHOLOGY; PATHOLOGY; PRIORITY JOURNAL;

EID: 0342940785     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)10109-4     Document Type: Article

References (29)

1. Hall JM, Lee MK, Newman B, et al. Linkage of early-onset familial breast cancer to chromosome 17q21. Science 1990; 250: 1684-89.
2. Miki Y, Swensen J, Shattuck Eidens D, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994; 266: 66-71.
3. Easton DF, Ford D, Bishop DT, et al. Breast and ovarian cancer incidence of BRCA-1 mutation carriers. Am J Hum Genet 1995; 56: 265-71.
4. Ford D, Easton DF, Bishop DT, et al. Risk of cancer in BRCA1-mutation carriers. Lancet 1994; 343: 692-95.
5. Wooster R, Neuhausen L, Mangion J, et al. Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science 1994; 265: 2088-90.
6. Wooster R, Bignell G, Lancaster J, et al. Identification of the breast cancer susceptibility gene BRCA2. Nature 1995; 378: 789-92.
7. Tavtigian SV, Simard J, Rommens J, et al. The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds. Nat Genet 1996; 12: 333-37.
8. Malkin D, Li FP, Strong LC, et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 1990; 250: 1233-38.
9. Nelen MR, Padberg GW, Peeters EAJ, et al. Localization of the gene for Cowden disease to chromosome 10q22-23. Nat Genet 1996; 13: 114-16.
10. Wooster R, Mangion J, Eeles R, et al. A germline mutation in the androgen receptor gene in two brothers with breast cancer and Reifenstein syndrome. Nat Genet 1992; 2: 132-34.
11. Krontiris TG, Devlin B, Karp DD, Robert NJ, Risch N. An assocation between the risk of cancer and mutations in the HRAS1 minisatellite locus. N Engl J Med 1993; 329: 517-23.
12. Marcus JN, Watson P, Page DL, Lynch HT. Pathology and heredity of breast cancer in younger women. Monogr Natl Cancer Inst 1994; 16: 23-34.
13. Lagios MD, Rose MR, Margolin FR. Tubular carcinoma of the breast: association with multicentricity, bilaterality, and family history of mammary carcinoma. Am J Clin Pathol 1980; 73: 25-30.
14. Lynch HT, Albano WA, Heieck JJ, et al. Genetics, biomarkers, and control of breast cancer: a review. Cancer Genet Cytogenet 1984; 13: 43-92.
15. Rosen PP, Lesser ML, Senie RT, Kinne DW. Epidemiology of breast carcinoma III: relationship of family history to tumor type. Cancer 1982; 50: 171-79.
16. Erdreich LS, Asal NR, Hoge AF. Morphologic types of breast cancer: age, bilaterality, and family history. South Med J 1980; 73: 28-32.
17. LiVolsi VA, Kelsey JL, Fischer DB, Holford TR, Mostow ED, Goldenberg IS. Effect of age at first childbirth on risk of developing specific histologic subtype of breast cancer. Cancer 1982; 49: 1937-40.
18. Claus EB, Risch N, Thompson WD, Carter D. Relationship between breast histopathology and family history of breast cancer. Cancer 1993; 71: 147-53.
19. Cannon Albright LA, Thomas A, Goldgar DE, et al. Familiality of cancer in Utah. Cancer Res 1994; 54: 2378-85.
20. Bignon YJ, Fonck Y, Chassagne M-C. Histoprognostic grade in tumours from families with hereditary predisposition to breast cancer. Lancet 1995; 346: 258.
21. Jacquemier J, Eisinger F, Birnbaum D, Sobol H. Histoprognostic grade in BRCA1-associated breast cancer. Lancet 1995; 345: 1503.
22. Marcus JN, Watson P, Page DL, et al. Hereditary breast cancer: pathobiology, prognosis and BRCA1 and BRCA2 linkage. Cancer 1996; 77: 697-709.
23. Eisinger F, Stoppa Lyonnet D, Longy M, et al. Germ line mutation at BRCA1 affects the histoprognostic grade in hereditary breast cancer. Cancer Res 1996; 56: 471-74.
24. UK National Coordinating Group for Breast Screening Pathology. Pathology reporting in breast cancer screening. NHSBSB publications, 1995.
25. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer I. The value of histopathological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 1991; 19: 403-10.
26. Huber PJ. The behaviour of maximum likelihood estimates under non standard conditions. Proc 5th Berkeley Symp Math Stat Prob 1967; 1: 221-33.
27. Fleiss JL. Statistical methods for rates and properties. New York: John Wiley, 1981.
28. Aaltomaa S, Lipponen P, Eskelinen M, et al. Histological assessment of the prognostic factors in female breast cancer. Oncology 1992; 49: 1-8.
29. Porter DE, Cohen BB, Wallace MR, et al. Breast cancer incidence, penetrance and survival in probable carriers of BRCA1 gene mutation in families linked to BRCA1 on chromosome 17q12-21. Br J Surg 1994; 81: 1512-15.